药品注册申请号:020884
申请类型:NDA (新药申请)
申请人:BOEHRINGER INGELHEIM
申请人全名:BOEHRINGER INGELHEIM PHARMACEUTICALS INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 AGGRENOX ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE;ORAL 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No AB 1999/11/22 1999/11/22 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2021/05/13 SUPPL-40(补充) Approval Labeling STANDARD
2019/12/11 SUPPL-39(补充) Approval Labeling STANDARD
2018/11/09 SUPPL-37(补充) Approval Labeling STANDARD
2015/11/09 SUPPL-35(补充) Approval Labeling STANDARD
2014/05/30 SUPPL-33(补充) Approval Manufacturing (CMC) PRIORITY
2013/05/29 SUPPL-32(补充) Approval Manufacturing (CMC) PRIORITY
2012/09/07 SUPPL-30(补充) Approval Labeling UNKNOWN
2009/10/01 SUPPL-18(补充) Approval Efficacy STANDARD
2007/03/26 SUPPL-12(补充) Approval Efficacy STANDARD
2006/11/28 SUPPL-14(补充) Approval Labeling STANDARD
2004/01/28 SUPPL-7(补充) Approval Labeling STANDARD
2002/06/20 SUPPL-6(补充) Approval Manufacturing (CMC) PRIORITY
2002/02/08 SUPPL-5(补充) Approval Manufacturing (CMC) PRIORITY
2001/09/21 SUPPL-4(补充) Approval Manufacturing (CMC) PRIORITY
2001/08/10 SUPPL-1(补充) Approval Labeling STANDARD
2001/04/23 SUPPL-3(补充) Approval Manufacturing (CMC) PRIORITY
2000/10/17 SUPPL-2(补充) Approval Manufacturing (CMC) PRIORITY
1999/11/22 ORIG-1(原始申请) Approval Type 4 - New Combination PRIORITY
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
001 6015577 2017/01/18 U-302 PDF格式**本条是由Drugfuture回溯的历史信息**
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:ASPIRIN; DIPYRIDAMOLE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
020884 001 NDA AGGRENOX ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE;ORAL 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Discontinued Yes No AB 1999/11/22 BOEHRINGER INGELHEIM
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database